Affiance Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Affiance Financial's GILD Position: Q2 2026 in Review
Affiance Financial increased its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, buying an estimated $2.37K and bringing the position to 2,792 shares worth $353K. The position accounts for 0.05% of the portfolio, ranked #88.
Affiance Financial first reported a position in GILD in Q1 2016 and has held it in 17 quarters since. The position peaked at $694K in Q1 2016. 1,014 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Affiance Financial held 2,792 shares of Gilead Sciences worth $353K as of Q2 2026.
- Affiance Financial bought 18 Gilead Sciences shares in Q2 2026, an estimated $2.37K.
- Gilead Sciences made up 0.05% of Affiance Financial's portfolio in Q2 2026, its #88 holding.
- Affiance Financial first reported a position in Gilead Sciences in Q1 2016 and has held it in 17 quarters since.
- Affiance Financial's Gilead Sciences position peaked at $694K in Q1 2016.
- 1,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.